Are E-Cigs Effective As a Smoking Cessation Tool?

Although some argue that e-cigarettes may help people quit smoking or have less harmful consequences than traditional cigarettes, a new study found that many e-cigarette users also use regular cigarettes, undermining the argument that e-cigs are a smoking cessation tool. The study also found that respiratory symptoms were most common among people who used both regular cigarettes and e-cigs.

Researchers in Sweden looked at more than 30,000 adults ranging in age from 20 to 75 years old. Among e-cig users, nearly two-thirds were current smokers, 18.3% were non-cigarette smokers and 15% were former smokers.

Respiratory symptoms were most common among those who used both e-cigs and tobacco cigarettes and former smokers who didn’t use e-cigs, according to the study, published in JAMA Network Open. Those symptoms included wheezing, long-standing cough and difficulty bringing up phlegm during coughs.

“The medical community needs to be careful when recommending e-cigarettes to patients as a smoking cessation method or as a safer alternative to conventional cigarettes, especially as their efficacy as a smoking cessation method is still ambiguous,” the researchers wrote. “Our study seems to indicate that the present use of e-cigarettes does not adequately serve as a smoking cessation tool.”


Did you find this article helpful?


Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

More Drugs Linked to Heart Failure

More Drugs Linked to Heart Failure

Pulmonary arterial hypertension is a disease of the lungs that can cause heart failure and death, and it’s being linked to an increasing number of common and oft-prescribed drugs. The journal Prescrire, reports that, as of 2020, amphetamines, immunosuppressants, certain cancer medications, and a handful of other select medications have been…

Significant Side Effects Seen in Early Trial of COVID-19 Vaccine

Significant Side Effects Seen in Early Trial of COVID-19 Vaccine

There’s a COVID-19 vaccine on the way — or so the Wednesday headlines, which heralded positive results from Pfizer and BioNTech’s early-stage trial of a vaccine for COVID-19, would lead you to believe. A closer look at the data, and the adverse effects, however, reveals that it’s probably too early…

  • Advertisement